Prism Calibration Centre

NABL CC-2480 · EU GMP Annex 15 · FDA Process Validation 2011 · Est. 2004

Performance
Qualification (PQ)

Gujarat's trusted PQ validation partner — worst-case process performance studies, 3-run consecutive PQ, statistical analysis (Cpk), continued process verification (CPV). Full protocols and GMP reports per EU GMP Annex 15, FDA 2011 guidance, ICH Q8/Q9/Q10. Onsite across Gujarat.

Performance Qualification PQ Validation Service Gujarat Prism Calibration Centre
EU GMP Annex 15FDA PV Guidance 2011ICH Q8 · Q9 · Q10ISPE Baseline GuideWHO TRS 961Schedule M IndiaDQ / IQ / OQ / PQWorst-Case PQ TestingProcess Capability (Cpk)Statistical Acceptance CriteriaContinued Process Verification20+ Years ExperienceEU GMP Annex 15FDA PV Guidance 2011ICH Q8 · Q9 · Q10ISPE Baseline GuideWHO TRS 961Schedule M IndiaDQ / IQ / OQ / PQWorst-Case PQ TestingProcess Capability (Cpk)Statistical Acceptance CriteriaContinued Process Verification20+ Years Experience
0+
Industries Served
Across Gujarat since 2004
0+
PQ Projects Completed
Pharma, biotech & devices
0+
Expert Engineers
GMP validation specialists
0%
Repeat Client Rate
Client satisfaction & trust

— WHAT IS PERFORMANCE QUALIFICATION —

PQ Validation —
Process Consistency Proven

Performance Qualification (PQ) provides documented, scientific evidence that your manufacturing process consistently produces product meeting all quality specifications under actual production conditions — at commercial scale, using approved raw materials, personnel, and procedures.

PQ is mandatory — not optional — under EU GMP Annex 15 and FDA guidance

EU GMP Annex 15 (2015) and FDA Process Validation Guidance (2011) mandate formal PQ for all pharmaceutical products. No product may be commercially marketed without documented PQ demonstrating process consistency — this applies to new products, site transfers, batch size changes, and equipment changes.

3 consecutive PQ runs at commercial scale are the regulatory baseline

A minimum of 3 consecutive successful PQ runs, each meeting all pre-defined acceptance criteria, is required by EU GMP Annex 15. Fewer runs require scientific justification. Each run must be at the commercial batch size using actual production conditions — not lab scale.

PQ failure = mandatory batch rejection and regulatory notification

If PQ runs fail to meet acceptance criteria, the process is not validated. Batches produced during a failed PQ run cannot be released unless re-testing is scientifically justified. Repeat PQ failures typically trigger CAPA and regulatory notification in sterile manufacturing.

PQ Acceptance Criteria Framework

EU GMP Annex 15 / FDA 2011 / ICH Q8–Q10

Minimum PQ runs

3 consecutive successful runs

Batch scale

Commercial scale only

Process capability

Cpk ≥ 1.33 for all CQAs

Sampling

Worst-case, bracketed, risk-based

CPV requirement

Stage 3 per FDA 2011 guidance

Report format

EU GMP Annex 15 compliant

— WHAT YOU GET —

Every PQ Engagement Includes

PQ Protocol Development

Comprehensive PQ protocol with test parameters, worst-case sampling plan, acceptance criteria, and statistical evaluation method — approved before execution per EU GMP Annex 15.

Worst-Case PQ Runs

Three consecutive PQ runs at commercial scale — worst-case bracketing at min/max batch size, speed, temperature, and critical process parameters to demonstrate full-range robustness.

Statistical Analysis (Cpk)

Process capability (Cp, Cpk), mean, SD, RSD, and SPC trending for all CQAs — confirming Cpk ≥ 1.33 per FDA 2011 guidance and regulatory expectation.

GMP PQ Report

Full PQ validation report in EU GMP Annex 15 format — run summaries, all analytical data, statistical analysis, deviation log, CAPA records, and conclusion. Accepted by USFDA, WHO, GPCB.

Fast Report Turnaround

Preliminary PQ run findings within 48 hours. Complete GMP PQ validation report with all annexures in 7–10 working days from run completion.

CPV Protocol Setup

Continued Process Verification (CPV) protocol and control chart setup per ICH Q10 and FDA Stage 3 — links PQ outcomes to ongoing APQR and process trending.

Deviation & CAPA Management

All deviations during PQ runs documented, investigated, and CAPAed in real time. No deviations go unaddressed in the final PQ report.

Onsite at Your Facility

Prism validation engineers work at your production facility for the full PQ campaign — no external laboratory, no sample transport risk, no production interruption.

Onsite Across Gujarat · EU GMP Annex 15 · FDA 2011 Guidance

Ready to Qualify Your Process?

Onsite service · 7–10 day report delivery · FDA, WHO, EU GMP accepted

— OUR PROCESS —

Performance Qualification Process

01
STEP 01

PQ Protocol Development

Prepare a comprehensive PQ protocol defining test parameters, sampling plan, worst-case conditions, acceptance criteria, and statistical evaluation method — aligned with EU GMP Annex 15, FDA Process Validation Guidance (2011), and ICH Q8/Q9/Q10.

02
STEP 02

Worst-Case Bracketing Study

Execute PQ runs at worst-case process parameters — minimum and maximum batch size, speed, temperature, humidity, and load configuration. Bracketing demonstrates process robustness across the full validated range.

03
STEP 03

Three Consecutive PQ Runs

Minimum 3 consecutive successful PQ runs at commercial scale, each meeting all pre-defined acceptance criteria — unless a continuous process verification (CPV) approach is used per FDA 2011 guidance.

04
STEP 04

In-Process & Finished Product Testing

Sampling at defined intervals during each PQ run: blend uniformity, content uniformity, tablet weight variation, dissolution, microbial limits, and all CQA parameters — per the approved PQ sampling plan.

05
STEP 05

Statistical Analysis & CPV

Process capability analysis (Cp, Cpk), statistical process control (SPC) trending, and continued process verification (CPV) setup per ICH Q10 and FDA Process Validation Guidance (2011) Stage 3 requirements.

06
STEP 06

GMP PQ Report Issued

Complete PQ validation report including run summaries, all analytical data, statistical analysis, deviation log, CAPA records, conclusion, and approval signatures — in EU GMP Annex 15 format, accepted by FDA, WHO, GPCB auditors.

Industry Applications

Industries That Require Performance Qualification

Solid Dose — Tablet & Capsule

PQ for tablet compression, encapsulation, blending, granulation, and coating processes — content uniformity, blend uniformity, dissolution, and hardness per USP/IP/BP and EU GMP Annex 15.

Know More

Sterile Manufacturing

PQ for sterile filling, lyophilization, sterilization-in-place (SIP), and aseptic processing. Media fill validation as part of aseptic process PQ per EU GMP Annex 1 (2022) and FDA guidance.

Know More

API Manufacturing

PQ for API synthesis, crystallization, drying, and milling processes — particle size, yield, purity, and residual solvent acceptance criteria per ICH Q8/Q9/Q10 and FDA 21 CFR Part 211.

Know More

Liquid & Semi-Solid Dose

PQ for oral liquid, topical cream, ointment, and gel manufacturing — homogeneity, viscosity, pH, microbial limits, and fill weight uniformity per EU GMP and Schedule M.

Know More

Medical Devices

PQ for medical device manufacturing processes — dimensional validation, sterility process PQ, sealing process PQ — per ISO 13485, ISO 11135, and EU MDR 2017/745.

Know More

Biotech & Biologics

PQ for bioreactor processes, purification, filtration, and fill-finish — process performance qualification (PPQ) per FDA Guidance for Industry (2011) and ICH Q8/Q9/Q10.

Know More

Nutraceutical & OTC Products

PQ for dietary supplement and OTC product manufacturing — blend uniformity, content uniformity, disintegration, and dissolution per FSSAI, GMP, and USP requirements.

Know More

Equipment & Utility Systems

PQ for equipment and utility systems including purified water (PW), water for injection (WFI), clean steam, compressed air, and nitrogen — per WHO, ISPE, and EU GMP standards.

Know More

Why Choose Prism

Two Decades of GMP Validation.
Zero Audit Observations.

Since 2004, every PQ validation report by Prism has been accepted by USFDA, WHO GMP, EU GMP, GPCB, and NABH auditors without a single observation.

EU GMP Annex 15 + FDA 2011 Methodology
Full alignment with EU GMP Annex 15 and FDA Process Validation Guidance (2011) — all 3 stages, Cpk analysis, CPV setup.
7–10 Day Report Delivery
Complete GMP PQ validation report with all data, statistical analysis, and signatures in 7–10 working days.
100% Onsite
All PQ execution at your production facility — no batch transport, no external lab.
ICH Q8/Q9/Q10 Aligned
Quality by Design, risk management, and quality systems approach embedded in every PQ — aligned with ICH Q8, Q9, Q10.
70+ Engineers
GMP PQ validation specialists
Same-Week Start
Rapid mobilisation for urgent PQ campaigns
Zero Observations
Every report FDA, WHO and GPCB accepted
All Gujarat
Every pharma GIDC zone covered onsite
500+ PQ Projects
Across pharma, biotech, and devices
Since 2004
20+ years of GMP compliance expertise

— STANDARDS & COMPLIANCE —

Standards We Follow for PQ Validation

EU GMP Annex 15 (2015)

Process validation & qualification

FDA PV Guidance (2011)

Process validation — 3-stage approach

ICH Q8 (R2)

Pharmaceutical development / QbD

ICH Q9 (R1)

Quality risk management

ICH Q10

Pharmaceutical quality systems / CPV

ISPE Baseline Guide Vol 5

Commissioning and qualification

Schedule M India (2023)

Indian GMP requirements

WHO TRS 961 (Annex 4)

WHO process validation supplement

EU GMP Annex 15 + FDA Process Validation Guidance (2011)

All PQ protocols and reports are authored per EU GMP Annex 15 and FDA Process Validation Guidance (2011). Statistical analysis (Cpk) and CPV setup included. Every report accepted in USFDA, WHO GMP, EU GMP, GPCB, and NABH audits.

500+

PQ Projects Done

0

Audit Observations

— REVALIDATION & LEGACY PRODUCTS —

PQ for Legacy Products & Process Changes

Marketed products without formal PQ documentation, site transfers, batch size changes, and equipment replacements all require revalidation PQ under EU GMP Annex 15. Prism conducts retrospective, concurrent, and prospective PQ for legacy and existing products.

Retrospective PQ from historical batch data (min 20–25 batches)
Concurrent PQ for new products during initial commercial runs
Prospective PQ for new products before market release
Revalidation PQ after batch size, equipment, or site changes
Post-CAPA revalidation after audit observations
Annual revalidation for critical processes per site SOPs

Retrospective PQ

Review of 20–25 commercial batches to establish validated process baseline — per EU GMP Annex 15 and FDA guidance.

Fast Campaign Start

PQ protocol ready in 5–7 days. Execution can begin within 2 weeks of engagement — suitable for urgent regulatory deadlines.

CPV Linkage

Every PQ is linked to CPV / APQR — so process trending continues beyond PQ closure per ICH Q10 Stage 3.

Change Control Ready

PQ reports authored in change control format — directly usable as change control closure evidence for equipment or process changes.

Onsite Coverage

Serving All
of Gujarat

Validation engineers based in Ahmedabad cover the full Gujarat pharma and industrial corridor onsite.

10 Major Cities · All GIDC Zones
Ahmedabad
Vadodara
Bharuch
Dahej
Ankleshwar
Surat
Rajkot
Gandhinagar
Nadiad
Anand

— Our Clients —

Trusted By Gujarat's Leading Pharma Companies

Zydus Lifesciences
Zydus Lifesciences
Pharmaceutical
Alembic Pharma
Alembic Pharma
Pharmaceutical
Sun Pharma
Sun Pharma
Pharmaceutical
ONGC
ONGC
Oil & Gas
Indian Oil
Indian Oil
Oil & Gas
NTPC
NTPC
Power & Energy
HPCL
HPCL
Oil & Gas
Adani Group
Adani Group
Conglomerate
Zydus Lifesciences
Zydus Lifesciences
Pharmaceutical
Alembic Pharma
Alembic Pharma
Pharmaceutical
Sun Pharma
Sun Pharma
Pharmaceutical
ONGC
ONGC
Oil & Gas
Indian Oil
Indian Oil
Oil & Gas
NTPC
NTPC
Power & Energy
HPCL
HPCL
Oil & Gas
Adani Group
Adani Group
Conglomerate

— CLIENT VOICES —

What Our PQ Validation Clients Say

Prism conducted PQ for our sterile filling line — worst-case bracketing, 3 consecutive runs, full statistical analysis. The PQ report was accepted in USFDA pre-approval inspection without a single observation. Exceptional depth of documentation.
Rajesh Mehta
Our tableting line PQ was completed in under two weeks by Prism, including CPV protocol and Annex 15 compliant report. Process capability (Cpk) analysis was thorough. WHO GMP audit accepted the report immediately.
Priya Desai
We engaged Prism for revalidation PQ after a batch size change. Full APQR-linked PQ with statistical trending. Prism's knowledge of EU GMP Annex 15 and FDA Process Validation Guidance (2011) is genuinely impressive. Five-year annual partnership.
Ankit Shah
Prism conducted PQ for our sterile filling line — worst-case bracketing, 3 consecutive runs, full statistical analysis. The PQ report was accepted in USFDA pre-approval inspection without a single observation. Exceptional depth of documentation.
Rajesh Mehta
Our tableting line PQ was completed in under two weeks by Prism, including CPV protocol and Annex 15 compliant report. Process capability (Cpk) analysis was thorough. WHO GMP audit accepted the report immediately.
Priya Desai
We engaged Prism for revalidation PQ after a batch size change. Full APQR-linked PQ with statistical trending. Prism's knowledge of EU GMP Annex 15 and FDA Process Validation Guidance (2011) is genuinely impressive. Five-year annual partnership.
Ankit Shah

Get In Touch

Request a Free Quote

Tell us your product type, dosage form, batch size, and validation trigger (new product, site transfer, batch size change). We respond within 2 hours.

Address
F-101, Rudraksh Complex 2, Phase 3, GIDC Vatva, Ahmedabad 382445

Send an Enquiry

— FAQ —

Performance Qualification — FAQ

Free quote within 2 working hours

Need PQ Validation in Gujarat?

Call or WhatsApp — we reply within the hour. Onsite across Gujarat, GMP report guaranteed.

Prism Calibration Centre · F 101, Rudraksh Complex 2, Phase 3, GIDC Vatva, Ahmedabad, Gujarat 382445

Validation Services Disclaimer

Performance Qualification services are performed per EU GMP Annex 15 (2015), FDA Process Validation Guidance (2011), ICH Q8/Q9/Q10, WHO TRS 961, and Schedule M (2023). All instruments used are NABL calibrated under Certificate CC-2480 (ISO/IEC 17025:2017).